Skip to content

Effect of Trikatu Gutika and Madhumehari Choorna in Diabetes

Comparative Clinical Study On The Efficacy Of Trikatu Gutika And Madhumehari Choorna In The Management Of Madhumeha With Special Reference To Type II Diabetes Mellitus.

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/12/010884
Enrollment
40
Registered
2017-12-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Madumeha (Diabetes Mellitus Type2)

Interventions

Intervention1: Trikatu Gutika: 1 gm tds for 1 month with lukewarm water Control Intervention1: Madhumehari Choorna: 5 gm BD for 1 month with lukewarm water

Sponsors

National Institute of Ayurveda
Lead Sponsor
Prof Ram Kishor Joshi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing to sign the consent form. 2. Patients between the ages of 30-70 years of either sex. 3. Patients giving the clinical history of DM (Type II). 4. Patients having hyperglycemia confirmed by laboratory investigations i.e. Fasting Blood Sugar (FBS) >= 126mg/dl or Post Prandial Blood Sugar (PPBS) >= 200mg/dl or Glycosylated Hemoglobin (HbA1c) >= 6.5%. 5. Presence of Cardinal symptoms of Diabetes Mellitus eg. (3P- polyuria, polydypsia, polyphagia).

Exclusion criteria

Exclusion criteria: 1. Patients below 30 years of age & above 70 years of age. 2. Patients having Type I DM. 3. Patients of Type II DM who are on insulin therapy. 4. Patients having any serious illness like Coronary Artery Disease (CAD), malignancy, etc. 5. Drug induced DM. 6. F.B.S. > 200 mg/dl and P.P.B.S. > 300 mg/dl. 7. Patients having chronicity of more than 5 years. 8. DM with complications. 9. Pregnant and lactating mother.

Design outcomes

Primary

MeasureTime frame
Reduction of Blood sugar levelTimepoint: 1 month

Secondary

MeasureTime frame
Reduction of risk of diabetes complicationsTimepoint: 1 month

Countries

India

Contacts

Public ContactDr Srishti Shrestha

National Institute of Ayurveda

joshirk1964@gmail.com9414322297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026